Teladoc Health, Inc.
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +77.8% | +59.2% | +89.4% | +79.1% | +32.4% | +97.7% | +85.8% | +18.4% | +8.1% | -1.3% | -1.5% | |
| – | +111.9% | +51.9% | +92.7% | +108.9% | +43.3% | +111.9% | +66.4% | +14.4% | +2.2% | -1.2% | +2.7% | |
| – | +67.7% | +61.8% | +88.2% | +68.5% | +27.6% | +90.6% | +96.6% | +20.3% | +10.8% | -1.3% | -3.3% | |
| – | +87.6% | +53.5% | +58.0% | +57.8% | +18.9% | +155.2% | +89.1% | +7.0% | +4.5% | -11.8% | -9.6% | |
| – | +168.8% | +3.2% | +60.7% | +42.8% | +36.0% | +208.1% | -13.6% | +2.7% | +3.3% | -6.3% | -0.8% | |
| – | +130.0% | +37.2% | +60.6% | +45.7% | +24.8% | +169.2% | +36.3% | +14.7% | +10.6% | +35.8% | -28.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +46.7% | +17.7% | +575.9% | +49.3% | +12.4% | +104.2% | +35.3% | -88.6% | +140.4% | +6.8% | -17.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.7% | +1,316.7% | -144.1% | – | -9,075.4% | – | – | -108.6% | – | +898.9% | -563.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -27.3% | +364.3% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.